BOSTON, Sept. 13, 2023 /PRNewswire/ -- ArisGlobal, a market-leader in global drug development technology solutions, announced today that medac, a German-based pharmaceutical manufacturer specializing in the fields of oncology and hematology, urology, and autoimmune diseases, has chosen LifeSphere Safety to modernize its drug safety processes. Precise, patient- and population-specific analysis is crucial for minimizing treatment risks for patients and thus supports the best possible treatment outcome.
Glycostem Therapeutics B.V., a leading clinical-stage company focused on the development of therapeutic allogeneic off-the-shelf Natural Killer (NK)...
Byondis B.V., an independent, Dutch clinical stage biopharmaceutical company, has entered into a License and Collaboration Agreement and a Supply Agreement with medac GmbH, a privately owned pharmaceutical company based in Germany.
When the German drugmaker Medac handed off a decades-old cancer compound to their US subsidiary in February, it thought it would be smooth sailing to market. After all, the drug had recently been approved in Europe and was available in Canada.
TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered into a licensing agreement, formalizing its relationship with medac GmbH (“medac”) to commercialize treosulfan, a bifunctional alkylating agent, in Canada.
Proceeds from the financing will be used to advance Vedanta’s clinical portfolio including a Phase 1/2 study of VE416 in food allergy, a Phase 1b/2 study of VE800 and OPDIVO (nivolumab) in advanced or metastatic cancers, and the ongoing Phase 2 study of VE303 in recurrent
Medac Pharma, Inc., a privately held, commercial-stage specialty pharmaceutical company, announced today the appointment of industry veteran Kevin O'Brien as Vice President of Sales for the company. In this role, Mr. O'Brien will lead all sales and sales training activities for the promotion of Rasuvo® (methotrexate) injection, Medac Pharma's first commercialized product in the U.S.
Medac`s Pemetrexed receive market authorisation in EU for Cancer